Today: 16 March 2026
Subscribe
Browse Category

LSE:RR. 13 November 2025

Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?

Rolls‑Royce Share Price Today (13 Nov 2025): RR.L edges lower after in‑line trading update as guidance held and flying hours rise

Rolls-Royce traded at 1,147.50p in early London trading, down 0.4% after reaffirming full-year profit and cash flow guidance in a scheduled update. The company reported large engine flying hours up 8% year-to-date, with demand from carriers including IndiGo and Malaysia Airlines. Shares remain near a 52-week high and have more than doubled in 2025.
13 November 2025
·
1 2

Stock Market Today

  • JNJ's Bladder Cancer Therapy Erda-iDRS Hits Primary Safety Endpoint in Early-Stage Trial
    March 16, 2026, 2:59 PM EDT. Johnson & Johnson's (JNJ) investigational bladder cancer treatment, Erda-iDRS, met its primary safety endpoint in a Phase I study targeting non-muscle-invasive bladder cancer (NMIBC) with FGFR gene alterations, found in up to 70% of intermediate-risk and 40% of high-risk patients. The localized drug-delivery system releases erdafitinib directly into the bladder, limiting systemic side effects. Results showed an 89% complete response (CR) rate in intermediate-risk patients, with median CR duration around 18 months. High-risk patients saw median recurrence-free survival of 20 months and 83% survival at 12 months. The therapy was generally well-tolerated with mild to moderate adverse effects and no dose-limiting toxicities. Shares of JNJ rose 36.3% over six months, outperforming the 17.2% industry gain, as the company prepares for further development steps.
Go toTop